Showing results (81-90 of 451) with videos related to
Sort By:
Pageof 46
Journal of the American Heart Association|January 25, 2023
Body Composition and Risk of Vascular-Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic DiseaseLouisa Gnatiuc Friedrichs, Rachel Wade, Jesus Alegre-Díaz, et al.Communications Medicine|November 14, 2022
Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adultsDiego Aguilar-Ramirez, William G Herrington, Jesus Alegre-Díaz, et al.Hepatology (Baltimore, Md.)|July 27, 2010
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective dataNazim Ghouri, David Preiss, Naveed SattarAnnals of Clinical Biochemistry|February 16, 2008
Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test resultsDavid Preiss, Louise Todd, Maurizio PanarelliAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.Lancet (London, England)|January 13, 2015
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials, Jordan Fulcher, Rachel O'Connell, et al.Annals of Internal Medicine|August 13, 2019
General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 AdultsLouisa Gnatiuc, Jesus Alegre-Díaz, Rachel Wade, et al.American Heart Journal|December 21, 2010
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial designDavid Preiss, Naveed Sattar, John J McMurrayNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 28, 2019
Chronic kidney disease, heart failure and neprilysin inhibitionRichard Haynes, Doreen Zhu, Parminder K Judge, et al.Pageof 46